ACT vs AZN · P/E 9.3, rev $629.4M vs P/E 28, $288.38B cap
Enact Holdings Inc (ACT) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
Enact Holdings Inc (ACT) is a insurance - specialty company listed on NASDAQ.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Latest reported ACT revenue for 2026-06-30 was $629.4M. ACT currently screens at market cap $5.99B and trailing P/E 9.3.
AZN does not have a complete income-statement cache yet.
ACT currently screens at market cap $5.99B and trailing P/E 9.3. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the ACT and AZN stock pages for the full models.
Not investment advice.